News blog

Newest NIH centre launches clinical trial

Researchers at the US National Institutes of Health are beginning a clinical trial for a rare, degenerative muscle disease. This is the first trial to start under the official endorsement of the National Center for Advancing Translational Sciences (NCATS) and was announced this week just as the first permanent head assumed leadership of the NIH’s newest institute. (See NIH insider will head translational medicine centre)  

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE